MedPath

Bicalutamide

Generic Name
Bicalutamide
Brand Names
Casodex
Drug Type
Small Molecule
Chemical Formula
C18H14F4N2O4S
CAS Number
90357-06-5
Unique Ingredient Identifier
A0Z3NAU9DP

Overview

Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. Bicalutamide binds to the androgen receptor.

Indication

Bicalutamide is indicated in combination with a luteinizing hormone-releasing hormone (LHRH) agonist for the treatment of Stage D2 metastatic carcinoma of the prostate.

Associated Conditions

  • Metastatic stage D2 Prostatic carcinoma

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/10/21
Phase 3
Recruiting
2024/07/30
Phase 2
Recruiting
2024/07/15
Phase 1
Not yet recruiting
2024/04/15
Phase 2
Recruiting
2024/01/24
Phase 1
Recruiting
2023/08/30
Phase 2
Withdrawn
CHU de Quebec-Universite Laval
2023/08/07
Phase 1
Recruiting
2022/12/12
Not Applicable
Not yet recruiting
Royal College of Surgeons, Ireland
2022/08/24
Phase 2
Recruiting
2022/04/14
Phase 2
Recruiting
CHU de Quebec-Universite Laval

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Kremers Urban
62175-132
ORAL
50 mg in 1 1
6/2/2009
Proficient Rx LP
71205-577
ORAL
50 mg in 1 1
11/1/2022
Physicians Total Care, Inc.
54868-4503
ORAL
50 mg in 1 1
1/27/2012
Physicians Total Care, Inc.
54868-6133
ORAL
50 mg in 1 1
8/11/2010
ANI Pharmaceuticals, Inc.
62559-890
ORAL
50 mg in 1 1
6/30/2020
Bryant Ranch Prepack
63629-8308
ORAL
50 mg in 1 1
8/12/2019
Accord Healthcare Inc.
16729-023
ORAL
50 mg in 1 1
1/16/2024
Golden State Medical Supply, Inc.
60429-177
ORAL
50 mg in 1 1
2/22/2024
ANI Pharmaceuticals, Inc.
62559-680
ORAL
50 mg in 1 1
8/30/2019
Sun Pharmaceutical Industries, Inc.
47335-485
ORAL
50 mg in 1 1
11/1/2018

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
BICAMED 50 BICALUTAMIDE TABLETS 50mg
SIN14824P
TABLET
50.000 mg
8/4/2015
CALUMEX FILM-COATED TABLETS 50MG
SIN15695P
TABLET, FILM COATED
50mg
5/24/2019
BICALOX TABLETS 50MG
SIN14145P
TABLET, FILM COATED
50MG
5/8/2012
BICALUTAMIDE STADA FILM COATED TABLET 50MG
SIN15134P
TABLET, FILM COATED
50mg
12/12/2016
CASODEX TABLET 50 mg
SIN09772P
TABLET, FILM COATED
50 mg
5/16/1998
CASODEX TABLET 150 mg
SIN11344P
TABLET, FILM COATED
150 mg
7/8/2000

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Bicalutamide Tablets
国药准字J20150050
化学药品
片剂
8/28/2019
Bicalutamide Tablets
国药准字HJ20140720
化学药品
片剂
11/30/2023
Bicalutamide Tablets
国药准字HJ20140719
化学药品
片剂
11/30/2023
Bicalutamide Tablets
国药准字H20244241
化学药品
片剂
6/28/2024
Bicalutamide Tablets
国药准字HJ20181036
化学药品
片剂
11/18/2022
Bicalutamide Tablets
国药准字HJ20181035
化学药品
片剂
11/18/2022
Bicalutamide Tablets
国药准字H20234422
化学药品
片剂
10/27/2023
Bicalutamide Tablets
国药准字H20064085
化学药品
片剂
6/23/2021
Bicalutamide Tablets
国药准字H20073877
化学药品
片剂
7/12/2022
Bicalutamide Tablets
国药准字H20113535
化学药品
片剂
8/16/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
HEXALIS TABLETS 150MG
N/A
N/A
N/A
4/24/2025
HEXALIS TABLETS 50MG
N/A
N/A
N/A
4/24/2025

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath